Optical Clearing Compositions Using Kramers-Kronig Index Matching

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing optical tissue clearing methods are not biocompatible and cannot be used in live organisms due to the use of toxic substances and the removal of vital molecules, limiting their effectiveness in reducing refractive index mismatch and scattering in biological tissues.

Innovation Solution

The use of absorbing substances that absorb light at specific wavelengths to modulate the refractive index of biological tissues, leveraging the Kramers-Kronig relation to increase the refractive index of the aqueous phase, thereby reducing scattering and increasing transmission, as demonstrated by the use of tartrazine as a safe and soluble pigment.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If existing optical tissue clearing methods use toxic substances and remove lipids to reduce refractive index mismatch, then light scattering is reduced and imaging depth is improved, but biocompatibility is lost and live organism imaging becomes impossible

Engineering Contradiction:
Improveimaging depthVSAvoidbiocompatibility
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent converts the harmful effect of light absorption into a beneficial one by using absorbing substances to modulate refractive index through the Kramers-Kronig relation. The absorption at one wavelength induces refractive index changes at neighboring wavelengths, reducing scattering without requiring toxic clearing agents or lipid removal, thereby enabling biocompatible optical clearing in live organisms

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The patent changes the physical parameter of refractive index by introducing absorbing substances that modify the optical properties of the aqueous phase. By tuning the absorption characteristics of these substances, the refractive index of the aqueous phase is modulated to match that of lipid-based components, reducing optical contrast and scattering while maintaining tissue viability

Inventive Principle:
Principle #35Parameter changes

2Loss of energy

If water and lipids are removed from tissues to reduce scattering, then optical transparency is improved, but vital molecules are lost and live organism imaging is precluded

Engineering Contradiction:
Improvelight scatteringVSAvoidwater and lipids
Core Design Contradiction:
Loss of energyVSLoss of substance

Solution Approach 1:

The patent introduces absorbing substances as intermediaries that mediate the optical properties of the tissue. These substances are introduced into the aqueous phase and modulate its refractive index to match that of lipid-based components, thereby reducing scattering without requiring the removal of water or lipids. This intermediary approach preserves the native tissue composition while achieving optical clearing

Inventive Principle:
Principle #24Intermediary (Mediator)

3Measurement precision

If high-RI chemicals are used to replace water and reduce refractive index differences, then optical contrast is reduced and scattering is minimized, but toxic substances are introduced that cannot be used in live tissues

Engineering Contradiction:
Improverefractive index matchingVSAvoidtoxicity
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent converts the harmful effect of light absorption into a beneficial one by using absorbing substances to modulate refractive index through the Kramers-Kronig relation. The absorption at one wavelength induces refractive index changes at neighboring wavelengths, reducing scattering without requiring toxic clearing agents or lipid removal, thereby enabling biocompatible optical clearing in live organisms

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The patent changes the physical parameter of refractive index by introducing absorbing substances that modify the optical properties of the aqueous phase. By tuning the absorption characteristics of these substances, the refractive index of the aqueous phase is modulated to match that of lipid-based components, reducing optical contrast and scattering while maintaining tissue viability

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables clear visualization of deep tissues in live organisms by increasing transmission and reducing scattering, allowing for non-invasive imaging of muscles, bones, and nerves without the use of toxic chemicals.

Implementation Method 1

an absorbing substance that absorbs light at specific wavelengths

Methodology Applied
Scientific EffectAbsorption (EM radiation): Absorption (EM radiation)

Implementation Method 2

allowing the refractive index of the medium at neighboring wavelengths to be modulated accordingly

Methodology Applied
Scientific EffectKramers-Kronig relation:

Implementation Method 3

reduction of the refractive index mismatch between separate phases with distinct refractive indices, thus mitigating scattering

Methodology Applied
Scientific EffectScattering: Scattering

Implementation Method 4

significantly increasing the refractive index at desired wavelengths

Methodology Applied
Scientific EffectRefraction: Refraction

Data Source

PatentUS20250367330A1Optical clearing enabled by the kramers-kronig relation
Publication Date: 2025.12.04 THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
  • US20250367330A1 patent drawing
  • US20250367330A1 patent drawing
  • US20250367330A1 patent drawing

AI summary

In one aspect, the disclosure relates to compositions and use thereof including an absorbing substance that absorbs light at specific wavelengths, thus allowing the refractive index of the medium at neighboring wavelengths to be modulated accordingly. This modulation allows reduction of the refractive index mismatch between separate phases with distinct refractive indices, thus mitigating scattering. The compositions are soluble in water and have high absorptivity, thus significantly increasing the refractive index at desired wavelengths. In one aspect, these materials have been proved safe in oral administration. In another aspect, provided herein is a protocol that enables diffusion of these substances into the aqueous phase of biological tissues, including in living organisms, thereby achieving increased transmission in muscles and allowing clear visualization of deep bones, vessels, and nerves that are otherwise invisible in the body.